Rotational Thromboelastometry-guided Transfusion in Major Obstetric Hemorrhage: A Case Series
DOI:
https://doi.org/10.24843/7nf7vg96Keywords:
Antifibrinolytic Agents, Hemostasis, Platelet Transfusion, Thromboelastography, Tranexamic AcidAbstract
Major obstetric hemorrhage remains a critical cause of maternal morbidity and mortality, requiring rapid yet precise transfusion management to prevent coagulopathy and adverse outcomes. We report a case series of seven obstetric patients with major perioperative hemorrhage managed using rotational thromboelastometry (ROTEM) guided transfusion at a tertiary referral center. The patients, predominantly with placenta accreta spectrum disorders, placenta previa, uterine atony, and one case of idiopathic thrombocytopenic purpura, experienced a wide range of estimated blood loss from 200 to 4500 mL. ROTEM assessment using EXTEM and FIBTEM parameters was performed during active bleeding to identify specific coagulation abnormalities and guide transfusion decisions. All patients received packed red cell transfusion, while fibrinogen replacement, fresh frozen plasma, platelet concentrates, and tranexamic acid were administered selectively based on viscoelastic findings rather than estimated blood loss alone. Four patients received tranexamic acid due to evidence of impaired clot stability, whereas others with preserved clot firmness were managed without empiric plasma or antifibrinolytic therapy despite significant hemorrhage. One patient with minimal bleeding required platelet transfusion after ROTEM detected qualitative platelet dysfunction. All patients achieved hemodynamic stabilization without major transfusion-related complications or need for reoperation. This case series highlights the clinical value of ROTEM in enabling goal-directed, individualized transfusion strategies in obstetric hemorrhage, emphasizing that viscoelastic-guided management may optimize hemostasis while limiting unnecessary blood product exposure.
Downloads
References
1. Collis R, French L. Massive obstetric haemorrhage. In: Fernando R, Sultan P, Phillips S, editors. Quick Hits in Obstetric Anesthesia. Cham: Springer; 2022. p. 121-9. doi:10.1007/978-3-030-72487-0_21.
2. Moore SA, Raval JS. Massive transfusion: a review. Ann Blood. 2022;7:15. doi:10.21037/aob-22-3.
3. Hutspardol S, Borja T, Kroeker J, Wang XQ, Mi J, Zamar D, et al. Comparison of conventional coagulation tests and ROTEM in identifying trauma-induced coagulopathy for massive haemorrhage protocol activation. Transfus Med. 2025;35(3):266-74. doi:10.1111/tme.13128.
4. Jokinen S, Kuitunen A, Uotila J, Yli-Hankala A. Thromboelastometry-guided treatment algorithm in postpartum haemorrhage: a randomised, controlled pilot trial. Br J Anaesth. 2023;130(2):165-74. doi:10.1016/j.bja.2022.10.031.
5. Setyawan NH, Permana SA. Massive transfusion in cesarean section patients with placenta accreta: a case series. Bali J Anaesthesiol. 2021;5:191-4.
6. Khanna P, Sinha C, Singh AK, Kumar A, Sarkar S. The role of point-of-care thromboelastography (TEG) and thromboelastometry (ROTEM) in management of primary postpartum haemorrhage: a meta-analysis and systematic review. Saudi J Anaesth. 2023;17(1):23-32. doi:10.4103/sja.sja_529_22.
7. Ronenson AM, Shifman EM, Kulikov AV, Raspopin YS, Gösrlinger K, Ioscovich AM, et al. Rotational thromboelastometry reference range during pregnancy, labor and postpartum period: a systematic review with meta-analysis. J Obstet Anaesth Crit Care. 2022;12(2):105. doi:10.4103/JOACC.JOACC_21_22
Downloads
Published
Data Availability Statement
The authors confirm that all necessary patient consent forms have been obtained. In these forms, the patient(s) provided informed consent for the publication of their images and relevant clinical information in the journal. The patients have been informed that while their names and initials will not be published and reasonable efforts will be made to protect their identity, complete anonymity cannot be guaranteed.
Issue
Section
License
Copyright (c) 2026 David, Tjahya Aryasa EM, Marilaeta Cindryani Ra Ratumasa (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share, use, distribute, and reproduce the work in any medium, provided the original author and source are properly credited.




